These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 29847724)

  • 1. Design and Synthesis of a Novel Series of Orally Bioavailable, CNS-Penetrant, Isoform Selective Phosphoinositide 3-Kinase γ (PI3Kγ) Inhibitors with Potential for the Treatment of Multiple Sclerosis (MS).
    Come JH; Collier PN; Henderson JA; Pierce AC; Davies RJ; Le Tiran A; O'Dowd H; Bandarage UK; Cao J; Deininger D; Grey R; Krueger EB; Lowe DB; Liang J; Liao Y; Messersmith D; Nanthakumar S; Sizensky E; Wang J; Xu J; Chin EY; Damagnez V; Doran JD; Dworakowski W; Griffith JP; Jacobs MD; Khare-Pandit S; Mahajan S; Moody CS; Aronov AM
    J Med Chem; 2018 Jun; 61(12):5245-5256. PubMed ID: 29847724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of Highly Isoform Selective Orally Bioavailable Phosphoinositide 3-Kinase (PI3K)-γ Inhibitors.
    Pemberton N; Mogemark M; Arlbrandt S; Bold P; Cox RJ; Gardelli C; Holden NS; Karabelas K; Karlsson J; Lever S; Li X; Lindmark H; Norberg M; Perry MWD; Petersen J; Rodrigo Blomqvist S; Thomas M; Tyrchan C; Westin Eriksson A; Zlatoidsky P; Öster L
    J Med Chem; 2018 Jun; 61(12):5435-5441. PubMed ID: 29852070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of Highly Isoform Selective Thiazolopiperidine Inhibitors of Phosphoinositide 3-Kinase γ.
    Collier PN; Messersmith D; Le Tiran A; Bandarage UK; Boucher C; Come J; Cottrell KM; Damagnez V; Doran JD; Griffith JP; Khare-Pandit S; Krueger EB; Ledeboer MW; Ledford B; Liao Y; Mahajan S; Moody CS; Roday S; Wang T; Xu J; Aronov AM
    J Med Chem; 2015 Jul; 58(14):5684-8. PubMed ID: 26121481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis for isoform selectivity in a class of benzothiazole inhibitors of phosphoinositide 3-kinase γ.
    Collier PN; Martinez-Botella G; Cornebise M; Cottrell KM; Doran JD; Griffith JP; Mahajan S; Maltais F; Moody CS; Huck EP; Wang T; Aronov AM
    J Med Chem; 2015 Jan; 58(1):517-21. PubMed ID: 24754609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphoinositide 3-kinase gamma (PI3Kgamma) inhibitors for the treatment of inflammation and autoimmune disease.
    Venable JD; Ameriks MK; Blevitt JM; Thurmond RL; Fung-Leung WP
    Recent Pat Inflamm Allergy Drug Discov; 2010 Jan; 4(1):1-15. PubMed ID: 20017720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of PI3Kgamma leads to increased leukocyte apoptosis and diminished severity of experimental autoimmune encephalomyelitis.
    Rodrigues DH; Vilela MC; Barcelos LS; Pinho V; Teixeira MM; Teixeira AL
    J Neuroimmunol; 2010 May; 222(1-2):90-4. PubMed ID: 20303183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Action mechanisms and structure-activity relationships of PI3Kgamma inhibitors on the enzyme: a molecular modeling study.
    Kuang RR; Qian F; Li Z; Wei DZ; Tang Y
    Eur J Med Chem; 2006 Apr; 41(4):558-65. PubMed ID: 16545498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and Synthesis of Soluble and Cell-Permeable PI3Kδ Inhibitors for Long-Acting Inhaled Administration.
    Perry MWD; Björhall K; Bonn B; Carlsson J; Chen Y; Eriksson A; Fredlund L; Hao H; Holden NS; Karabelas K; Lindmark H; Liu F; Pemberton N; Petersen J; Rodrigo Blomqvist S; Smith RW; Svensson T; Terstiege I; Tyrchan C; Yang W; Zhao S; Öster L
    J Med Chem; 2017 Jun; 60(12):5057-5071. PubMed ID: 28520415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery and Lead-Optimization of 4,5-Dihydropyrazoles as Mono-Kinase Selective, Orally Bioavailable and Efficacious Inhibitors of Receptor Interacting Protein 1 (RIP1) Kinase.
    Harris PA; Faucher N; George N; Eidam PM; King BW; White GV; Anderson NA; Bandyopadhyay D; Beal AM; Beneton V; Berger SB; Campobasso N; Campos S; Capriotti CA; Cox JA; Daugan A; Donche F; Fouchet MH; Finger JN; Geddes B; Gough PJ; Grondin P; Hoffman BL; Hoffman SJ; Hutchinson SE; Jeong JU; Jigorel E; Lamoureux P; Leister LK; Lich JD; Mahajan MK; Meslamani J; Mosley JE; Nagilla R; Nassau PM; Ng SL; Ouellette MT; Pasikanti KK; Potvain F; Reilly MA; Rivera EJ; Sautet S; Schaeffer MC; Sehon CA; Sun H; Thorpe JH; Totoritis RD; Ward P; Wellaway N; Wisnoski DD; Woolven JM; Bertin J; Marquis RW
    J Med Chem; 2019 May; 62(10):5096-5110. PubMed ID: 31013427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A versatile high-throughput screen for inhibitors of lipid kinase activity: development of an immobilized phospholipid plate assay for phosphoinositide 3-kinase gamma.
    Fuchikami K; Togame H; Sagara A; Satoh T; Gantner F; Bacon KB; Reinemer P
    J Biomol Screen; 2002 Oct; 7(5):441-50. PubMed ID: 14599360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of Potent and Selective PI3Kγ Inhibitors.
    Drew SL; Thomas-Tran R; Beatty JW; Fournier J; Lawson KV; Miles DH; Mata G; Sharif EU; Yan X; Mailyan AK; Ginn E; Chen J; Wong K; Soni D; Dhanota P; Chen PY; Shaqfeh SG; Meleza C; Pham AT; Chen A; Zhao X; Banuelos J; Jin L; Schindler U; Walters MJ; Young SW; Walker NP; Leleti MR; Powers JP; Jeffrey JL
    J Med Chem; 2020 Oct; 63(19):11235-11257. PubMed ID: 32865410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small molecule inhibitors of phosphoinositide 3-kinase (PI3K) delta and gamma.
    Ameriks MK; Venable JD
    Curr Top Med Chem; 2009; 9(8):738-53. PubMed ID: 19689378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational Design of Novel Phosphoinositide 3-Kinase Gamma (PI3Kγ) Selective Inhibitors: A Computational Investigation Integrating 3D-QSAR, Molecular Docking and Molecular Dynamics Simulation.
    Li K; Zhu J; Xu L; Jin J
    Chem Biodivers; 2019 Jul; 16(7):e1900105. PubMed ID: 31111650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of a novel series of potent and orally bioavailable phosphoinositide 3-kinase γ inhibitors.
    Leahy JW; Buhr CA; Johnson HW; Kim BG; Baik T; Cannoy J; Forsyth TP; Jeong JW; Lee MS; Ma S; Noson K; Wang L; Williams M; Nuss JM; Brooks E; Foster P; Goon L; Heald N; Holst C; Jaeger C; Lam S; Lougheed J; Nguyen L; Plonowski A; Song J; Stout T; Wu X; Yakes MF; Yu P; Zhang W; Lamb P; Raeber O
    J Med Chem; 2012 Jun; 55(11):5467-82. PubMed ID: 22548342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A class of highly selective inhibitors bind to an active state of PI3Kγ.
    Gangadhara G; Dahl G; Bohnacker T; Rae R; Gunnarsson J; Blaho S; Öster L; Lindmark H; Karabelas K; Pemberton N; Tyrchan C; Mogemark M; Wymann MP; Williams RL; Perry MWD; Papavoine T; Petersen J
    Nat Chem Biol; 2019 Apr; 15(4):348-357. PubMed ID: 30718815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-based virtual screening approach to the discovery of phosphoinositide 3-kinase alpha inhibitors.
    Park H; Choi H; Hong S; Kim D; Oh DS; Hong S
    Bioorg Med Chem Lett; 2011 Apr; 21(7):2021-4. PubMed ID: 21354792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of Potent, Efficient, and Selective Inhibitors of Phosphoinositide 3-Kinase δ through a Deconstruction and Regrowth Approach.
    Barton N; Convery M; Cooper AWJ; Down K; Hamblin JN; Inglis G; Peace S; Rowedder J; Rowland P; Taylor JA; Wellaway N
    J Med Chem; 2018 Dec; 61(24):11061-11073. PubMed ID: 30532965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isoform selective phosphoinositide 3-kinase gamma and delta inhibitors and their therapeutic potential.
    Ghigo A; Hirsch E
    Recent Pat Inflamm Allergy Drug Discov; 2008 Jan; 2(1):1-10. PubMed ID: 19075988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding selectivity studies of phosphoinositide 3-kinases using free energy calculations.
    Sabbah DA; Vennerstrom JL; Zhong HA
    J Chem Inf Model; 2012 Dec; 52(12):3213-24. PubMed ID: 23157418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rational design of phosphoinositide 3-kinase α inhibitors that exhibit selectivity over the phosphoinositide 3-kinase β isoform.
    Heffron TP; Wei B; Olivero A; Staben ST; Tsui V; Do S; Dotson J; Folkes AJ; Goldsmith P; Goldsmith R; Gunzner J; Lesnick J; Lewis C; Mathieu S; Nonomiya J; Shuttleworth S; Sutherlin DP; Wan NC; Wang S; Wiesmann C; Zhu BY
    J Med Chem; 2011 Nov; 54(22):7815-33. PubMed ID: 21985639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.